Transcatheter closure has been widely accepted as a highly effective way to treat abnormal
blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of …

ABSTRACT Introduction: Since King and Mills' pioneering work in percutaneous closure
devices of secundum atrial septal defects (ASD) four decades ago, developments in device …

In the last decade, percutaneous atrial septal defect (ASD) closure has become the
treatment of choice in most clinical presentations of ASD. Percutaneous ASD closure has …

A congenital or iatrogenic tissue defect often requires closure by open surgery or metallic
components that can erode tissue. Biodegradable, hydrophobic light-activated adhesives …

Introduction In the search for a biodegradable device that leaves nothing but the tissue of the
patient after complete endotheliazation and absorption, the BioSTAR® device was …

Atrial septal defect (ASD) is a common structural congenital heart disease. With the
development of interventional closure devices and transcatheter techniques, interventional …

Abstract Purpose of Review Cardiac catheterization therapies to treat or palliate infants,
children and adults with congenital heart disease have developed rapidly worldwide in both …

Coronary artery fistulae are a rare cardiovascular anomaly. Even less common are multiple
fistulae involving more than 1 coronary artery. Herein we report the case of a 47-year-old …

The desire to avoid cardiopulmonary bypass, multiple redo sternotomies, and long hospital
stays has fueled the development of techniques and technologies that allow excellent …

Cardiovascular disease is a major cause of morbidity and mortality, especially in developed
countries. Most academic research efforts in cardiovascular disease management focus on …